The Role of GIP in New Weight Loss Medications Tirzepatide (Mounjaro) Tirzepatide is a GIP and GLP-1 receptor agonist approved for the treatment of type 2 diabetes and studied extensively for obesity
For emergencies, call 999
A total of 165 ALDH7A1 pathogenic variants have been reported in the literature, but no clear genotype-phenotype correlation has been established
Peptides like Ipamorelin are gaining traction for their ability to modulate the aging process through GH optimization and cellular repair. Sonnenschein, Journal of Peptide Science Why Is Ipamorelin So Popular
Although osteoarthritis is the most common condition causing knee pain, there many other causes of joint pain, such as ligament injuries, tears of the meniscus (the shock absorbers of the knee), infection, nerve conditions, and immune disorders
When was the Tambopata National Reserve created